ArticleFrontiers in oncology2026
Endoscopic nasopharyngectomy for recurrent or persistent nasopharyngeal carcinoma: a 10-year outcome from a tertiary centre in Hong Kong.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To analyse the outcomes of endoscopic nasopharyngectomy for recurrent or persistent nasopharyngeal carcinoma (NPC) in Prince of Wales Hospital (PWH), a tertiary hospital in Hong Kong. Methods: A retrospective review on patients who underwent endoscopic nasopharyngectomy in PWH between 2015 to 2025. Patient characteristics, disease status, operative complications, resection margins, need for adjuvant treatment, recurrence and survival outcomes were analysed. Results: A total of 42 subjects, including 39 recurrent NPC and 3 persistent NPC, were recruited in this study. For disease status, 33 had T1 disease, 5 had T2 disease, and 4 had T3 disease. Only 1 patient had post-operative haemorrhage requiring tracheostomy with no other major complication noted. Negative margin was achieved in 25 patients, whilst 5 patients had close margin (<1mm) and 12 patients had positive margin in final pathology. The 5-year overall survival rate is 77% and 5-year disease-free survival rate is 60%. Prognostic factor analysis showed that patients with negative surgical margin had better disease-free survival. Postoperative adjuvant radiotherapy for positive or close margin did not provide survival benefits in this cohort. Conclusion: Endoscopic nasopharyngectomy for recurrent or persistent NPC in our centre is of low complication rate, with comparable survival outcomes to other centres in the literature. Margin status is a significant prognostic factor for disease-free survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.